Immunocompromised Hoosiers and Booster Shots

Almost two weeks ago, the CDC voted to approve a third dose of the Pfizer or Moderna COVID-19 vaccine for immunocompromised Americans, ages 12 and older.

That's nearly 3% of the US population.